Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Causalus Pharmacy Partners Oy
OY
In liquidation
Y-tunnus 3170813-2
Lapinlahdenkatu 16
Fund management activities · NACE 6630
Est. 2020
— employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
EUR 0
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit 2024
EUR 0
EBITDA — year on year
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
EUR 0
—
EBITDA
EUR 0
—
Net profit
EUR 0
—
Total assets
EUR 0
—
Equity
EUR 0
—
Employees
—
—
Company information
Legal name
Causalus Pharmacy Partners Oy
Y-tunnus number
3170813-2
Legal form
Osakeyhtiö
NACE code
6630 · Fund management activities
Founded
13. marraskuuta 2020
Share capital
EUR 0
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selvitystilan aikana selvitysmies yksin
Company purpose
Holding-yhtiö.
Contact
Address
Lapinlahdenkatu 16
Phone
+3580407209123
Email
eeva.savela@apteekit.net
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Fund management activities
Companies in Helsinki
All Finland companies
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2021
0M
2023
0M
2024
EBITDA
EUR millions
0M
0M
1M
1M
1M
0M
2021
0M
2023
0M
2024
Income statement
EUR thousands
Item
2021
2023
2024
Revenue
0
0
0
Staff expenses
—
−0
−0
EBITDA
−0
0
0
Depreciation & amort.
—
−0
−0
EBIT
−0
0
0
Net financials
−0
0
0
Profit before tax
−0
0
0
Tax
−0
−0
−0
Net profit
−0
0
0
Balance sheet
EUR thousands
Item
2021
2023
2024
Total assets
21
0
0
Equity
21
0
0
Long-term debt
—
0
0
Short-term debt
0
0
0
Total debt
0
0
0
Financial ratios
5-year trend
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
2021
2024
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
2021
2024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
2021
2024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
2021
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2024
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2020-11-10 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
PA
Pauli Antero Puirava
Liquidator
Liquidator
2024
Former (2)
WZ
Wintom Zecarias Ghbre Selassie
Deputy Member
Deputy Member
2022 – 2024
PM
Panu Matti Engelvuori
Deputy Member
Deputy Member
2020 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Former (1)
EM
Eeva Mirjami Savela
Chairperson
2020 – 2024
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Causalus Pharmacy Partners Oy also hold positions in
0
other companies.
Person
Role here
Other companies
Pauli Antero Puirava
Liquidator
0 companies
Wintom Zecarias Ghbre Selassie
Deputy Member
0 companies
Panu Matti Engelvuori
Deputy Member
0 companies
Eeva Mirjami Savela
Chairperson
0 companies